What does CUSIP 800677106 represent in this 13F holders report?

CUSIP 800677106 is the security identifier for SGMO - SANGAMO THERAPEUTICS, INC - Common Stock used to aggregate holder disclosures.

How many institutions held SGMO - SANGAMO THERAPEUTICS, INC - Common Stock in Q2 2019?

178 institutional investors reported SGMO - SANGAMO THERAPEUTICS, INC - Common Stock for Q2 2019. Use the holders table for investor-level position and value details.

SANGAMO THERAPEUTICS, INC - Common Stock (SGMO)

CUSIP: 800677106

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Stock
Shares outstanding: 294,683,714
Total 13F shares: 79,874,675
Share change: +17,352,985
Total reported value: $860,158,811
Put/Call ratio: 66%
Price per share: $10.77
Number of holders: 178
Value change: +$188,076,135
Number of buys: 106
Number of sells: 65

Quarterly Holders Quick Answers

What is CUSIP 800677106?
CUSIP 800677106 identifies SGMO - SANGAMO THERAPEUTICS, INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 800677106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SGMO - SANGAMO THERAPEUTICS, INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	2.8%	8,334,148	$79,508,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	2.6%	7,712,588	$73,578,000	—	31 Mar 2019	13F
WASATCH ADVISORS LP	13F	Company	2.2%	6,437,908	$61,418,000	—	31 Mar 2019	13F
STATE STREET CORP	13F	Company	2%	5,852,641	$55,834,000	—	31 Mar 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.5%	4,313,453	$41,150,000	—	31 Mar 2019	13F
BB BIOTECH AG	13F	Company	0.9%	2,650,000	$25,281,000	—	31 Mar 2019	13F
FMR LLC	13F	Company	0.83%	2,444,721	$23,323,000	—	31 Mar 2019	13F
CREDIT SUISSE AG/	13F	Company	0.8%	2,346,344	$22,385,000	—	31 Mar 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.51%	1,516,660	$14,468,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	0.45%	1,322,332	$12,615,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.43%	1,252,473	$11,948,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.41%	1,195,841	$11,408,000	—	31 Mar 2019	13F
Casdin Capital, LLC	13F	Company	0.37%	1,080,000	$10,303,000	—	31 Mar 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	0.34%	999,823	$9,538,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.33%	975,447	$9,303,000	—	31 Mar 2019	13F
Alexandria Capital, LLC	13F	Company	0.31%	916,153	$8,740,000	—	31 Mar 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.31%	905,200	$8,636,000	—	31 Mar 2019	13F
Invesco Ltd.	13F	Company	0.3%	896,067	$8,548,000	—	31 Mar 2019	13F
Rhenman & Partners Asset Management AB	13F	Company	0.29%	843,957	$8,051,000	—	31 Mar 2019	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.24%	698,982	$6,668,289	—	31 Mar 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.22%	656,636	$6,265,000	—	31 Mar 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.2%	589,896	$5,628,000	—	31 Mar 2019	13F
MORGAN STANLEY	13F	Company	0.18%	530,968	$5,065,000	—	31 Mar 2019	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.17%	496,753	$4,739,000	—	31 Mar 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.17%	490,826	$4,683,000	—	31 Mar 2019	13F
Bank of New York Mellon Corp	13F	Company	0.16%	469,447	$4,478,000	—	31 Mar 2019	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.15%	434,941	$4,149,000	—	31 Mar 2019	13F
ALTRINSIC GLOBAL ADVISORS LLC	13F	Company	0.14%	416,500	$3,973,000	—	31 Mar 2019	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.14%	415,256	$3,962,000	—	31 Mar 2019	13F
Artal Group S.A.	13F	Company	0.14%	400,000	$3,816,000	—	31 Mar 2019	13F
TEACHERS ADVISORS, LLC	13F	Company	0.12%	347,822	$3,318,000	—	31 Mar 2019	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.1%	308,717	$2,946,000	—	31 Mar 2019	13F
Rafferty Asset Management, LLC	13F	Company	0.1%	285,512	$2,724,000	—	31 Mar 2019	13F
Allianz Asset Management GmbH	13F	Company	0.09%	279,915	$2,670,000	—	31 Mar 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.09%	256,692	$2,449,000	—	31 Mar 2019	13F
Tekla Capital Management LLC	13F	Company	0.08%	241,538	$2,304,000	—	31 Mar 2019	13F
Gamma As Sector	13F	Individual	0.08%	238,857	$2,279,000	—	31 Mar 2019	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.08%	223,900	$2,136,000	—	31 Mar 2019	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.07%	197,600	$1,885,000	—	31 Mar 2019	13F
Swiss National Bank	13F	Company	0.06%	186,060	$1,775,000	—	31 Mar 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.06%	179,575	$1,713,000	—	31 Mar 2019	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.06%	168,585	$1,608,000	—	31 Mar 2019	13F
BARCLAYS PLC	13F	Company	0.05%	159,682	$1,523,000	—	31 Mar 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.05%	156,415	$1,492,000	—	31 Mar 2019	13F
BAILARD, INC.	13F	Company	0.05%	156,100	$1,489,000	—	31 Mar 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.05%	143,041	$1,365,000	—	31 Mar 2019	13F
TOCQUEVILLE ASSET MANAGEMENT L.P.	13F	Company	0.05%	141,137	$1,346,000	—	31 Mar 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.05%	137,036	$1,307,000	—	31 Mar 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	132,599	$1,265,000	—	31 Mar 2019	13F
QS Investors, LLC	13F	Company	0.04%	130,913	$1,249,000	—	31 Mar 2019	13F

Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q2 2019

As of 30 Jun 2019, SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) was held by 178 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 79,874,675 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, WASATCH ADVISORS INC, STATE STREET CORP, Bellevue Group AG, FMR LLC, CREDIT SUISSE AG/, DIMENSIONAL FUND ADVISORS LP, and CITADEL ADVISORS LLC. This page lists 178 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

178

Q2 2019 holders

178

Holder diff

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.